|
2nd Annual Market & Patient Access for Chronic Disease Therapies 2010 is an important event that aims to discuss the long term pricing and reimbursement strategies to penetrate significant growth markets. This conference is targeted at the industry decision makers and professionals who deal with Pricing & Reimbursement, Market-Access, Health Outcomes, Health Economics, Payer-Relations, Government Affairs, Regulatory Affairs, Medical, and Marketing sectors. Leaders will talk about the most recent solutions, future trends, and their experiences regarding strategies to contain and manage chronic disease growth with an ageing population. They will help others to improve outcomes and market-access and therefore disease management. Attendees will learn the true growth potential in major chronic therapeutic areas and their specific challenges and opportunities. They would also get a chance to see product-value demonstration by market leaders. The participants will get a focused picture of today's innovative, cost containment and reimbursement models. This will help them to understand how stakeholder mapping and building a value proposition for HTA affects market-access results. This episode will provide the members a chance to network co-operate, benchmark with key opinion leaders and policy makers.
Visitor Profile
The visitors at the 2nd Annual Market & Patient Access for Chronic Disease Therapies 2010 would include:
- Vice-Presidents
- Directors
- Country heads
- Brand managers
- Product managers
- CEOs
- Business development officers
- Senior consultants
- Regional heads
- Consultants
- Solution providers
Organizer
NextLevel Pharma